Status:
COMPLETED
Prognostic Factors of Patients With COVID-19
Lead Sponsor:
Chongqing Medical University
Conditions:
SARS-CoV-2
Outcome, Fatal
Eligibility:
All Genders
18+ years
Brief Summary
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern...
Eligibility Criteria
Inclusion
- Adult aged \>=18years old;
- Diagnosed with CONVID19. Diagnostic criteria including: Laboratory (RT-PCR) confirmed SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral pneumonia.
- Criteria for severe or critical ill conditions: Respiratory rate \>=30/min; or Rest SPO2\<=93%; or PaO2/FiO2\<=300mmHg.
Exclusion
- Near-death state (expected survival time less than 24 hours);
- Malignant tumor;
- Pregnancy or puerperium women;
- Patients who refused to participant.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 13 2020
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT04292964
Start Date
March 1 2020
End Date
March 13 2020
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China